Arch Venture Partners raises $400 million fund

[riky]

Arch Venture Partners raises $400 million fund

Chicago-based Arch Venture Partners raised a $400 million fund to invest in early stage companies, the firm announced Wednesday, underscoring renewed investor confidence in the once moribund life sciences sector. Arch is best known for healthcare and biotech, with portfolio companies including Agios Pharmaceuticals Inc, Bluebird Bio and Receptos Inc. Those companies held initial public offerings last year and have since more than doubled their prices.

Source: You are not allowed to view links. Register or Login